Neuroblastoma is composed of biologically varied tumors. This book provides an extensive analysis into the current prevalence of the disease and its future treatment modalities. Genomic/molecular properties exclusive to the specific tumors firmly link to the clinical results of patients. Formulation of risk stratification models post the analysis of biological characteristics of every case has resulted in huge success in patient management. Nevertheless,...